Interní Med. 2007; 9(9): 398-400

Lyme disease and musculoskeletal system

MUDr. Martin ®urek
III. interní klinika FN a LF UP Olomouc

Lyme disease is an infectious disease caused by spirochetes of Borrelia strain. The disease course has several phases and its manifestation is diverse. Musculoskeletal complains may present in any phase of Lyme disease. Artralgias occur in early phase together with erythema migrans without any objective finding on joints and may persist for many months or years. Intermittent arthritis that manifests already in early phase of borreliosis is usually monoarticular or oligoarticular and asymmetric. The frequency of flares of intermittent articular inflammations decreases with time. Chronic lyme arthiritis is very frequently limited to one joint, typically a knee and is characterized by large recurrent joint effusions. The diagnosis of Lyme disease with musculoskeletal manifestation is complex and is base on typical clinical findings, serologic examination (ELISA + confirmatory test, Western blot, immunoblot). The base of treatment of articular manifestation of Lyme disease is a longterm antibiotic treatment.

Keywords: Lyme disease, diagnosis, treatment

Published: January 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
®urek M. Lyme disease and musculoskeletal system. Interní Med. 2007;9(9):398-400.
Download citation

References

  1. Bentas W, Karch H, Huppertz, HI. Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy. J Rheumatol 2000; 27: 2025. Go to PubMed...
  2. Bettina W, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol. 2007; 49 (1): 13-21. Go to original source... Go to PubMed...
  3. Carlson D, Hernandez J, Bloom BJ et al. Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum 1999; 42: 2705. Go to original source...
  4. Dattwyler RJ, Luft BJ, Kunkel MJ et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med 1997; 337: 289. Go to original source... Go to PubMed...
  5. Dattwyler RJ, Volkman DJ, Conaty SM, Platkin SP, Luft BJ. Amoxicillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet 1990; 336: 1404. Go to original source... Go to PubMed...
  6. Dattwyler RJ, Volkman DJ, Luft, BJ et al. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med 1988; 319: 1441. Go to original source... Go to PubMed...
  7. De Silva AM, Fikrig E. Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding. Am J Trop Med Hyg 1995; 53 (4): 397-404. Go to original source... Go to PubMed...
  8. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993; 167: 392. Go to original source... Go to PubMed...
  9. Jaulhac B, Chary-Valckenaere I, Sibilia J et al. Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis Rheum 1996; 39: 736. Go to original source... Go to PubMed...
  10. Kalish RA, McHugh G, Granquist J et al. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis 2001; 33: 780. Go to original source... Go to PubMed...
  11. Lawson JP, Steere AC. Lyme arthritis: Radiologic findings. Radiology 1985; 154: 37. Go to original source... Go to PubMed...
  12. Luger SW, Paparone P, Wormser GP et al. Comparison of cefuroxime axetil and doxycycline intreatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother 1995; 39: 661. Go to original source... Go to PubMed...
  13. Nadelman RB, Luger SW, Frank E et al. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann Intern Med 1992; 117: 273. Go to original source... Go to PubMed...
  14. Sigal LH, Plescia O. Antibodies: structure and function. In: Immunology and inflammation: basic mechanisms and clinical consequences, Sigal, LH, Ron, Y (Eds), McGraw-Hill, New York 1993.
  15. Steere AC, Sikand VK, Meurice F et al. Vaccination against Lyme disease¨with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med 1998; 339: 209-15. Go to original source... Go to PubMed...
  16. Steere AC, Levin RE, Molloy PJ et al. Treatment of Lyme arthritis. Arthritis Rheum 1994; 37: 878. Go to original source... Go to PubMed...
  17. Steere AC, Malawista SE, Snydman DR et al. Lyme arthritis. An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977; 20: 7. Go to original source... Go to PubMed...
  18. Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med 1987; 107: 725. Go to original source... Go to PubMed...
  19. Steere AC. Lyme disease. N Engl J Med 1989; 321: 586. Go to original source... Go to PubMed...
  20. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995; 44: 590-1.
  21. Dejmkova H. terapie lymeské artritidy. In: Pavelka K a kol. Farmakoterapie revmatologických onemocnění. Grada Publishing 2005: 335-339.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.